11 active locations
The Sublocade family currently covers Brooklyn, Queens, the Bronx, Manhattan, and Long Island so the treatment plan does not depend on one hard-to-reach clinic.
Monthly injection treatment works better when the site is realistic to return to. Local clinic details keep the practical part simple: address, directions, local booking, and repeat monthly access.
Coverage depends on your exact plan, clinician, location and service. Check participation and expected charges with the clinic and your insurer before booking.
Confirm the specific service at the intended site before traveling. Ask which part of evaluation and follow-up takes place there, how to arrange it and whether your chosen treatment is available at that location.
Ask whether the site performs the evaluation, receives medication through the certified pathway and administers Sublocade. If you are new to buprenorphine, clarify where the supervised tolerability assessment and post-injection observation happen. Booking an evaluation does not establish that the depot has arrived.
Confirm where the second injection and subsequent monthly care occur. Early scheduling can differ from maintenance. Explain travel and work constraints and ask whom to contact if the site or delivery plan changes. Discuss a ride if treatment affects alertness; transport is not automatically included.
Sublocade is a long-acting buprenorphine injection for moderate to severe opioid use disorder. A clinician gives it under the skin; you do not take it home or inject it yourself. It can replace the daily task of taking a buprenorphine film or tablet for some patients. The decision also depends on withdrawal risk, your response to buprenorphine, health history and whether you can return for ongoing care.
Buprenorphine partly activates opioid receptors and can reduce opioid withdrawal and cravings. The injection forms a depot that releases medicine over time. It is still an opioid medicine and can cause physical dependence. Its long action may help with medication routines, but it also means a dose cannot be quickly adjusted after an injection.
The evaluation first confirms opioid use disorder and reviews recent fentanyl, heroin, pain-pill, methadone and buprenorphine use. Some patients already taking transmucosal buprenorphine can transition directly. Patients who are new to buprenorphine need a supervised first dose and assessment of tolerability. Pregnancy, liver disease, breathing problems and sedating medicines require an individualized discussion; moderate or severe liver impairment can make this depot unsuitable.
Bring the name and strength of your current product, the last dose, your usual schedule and any gaps. Describe cravings, withdrawal, sedation, substance use and previous overdoses. These details help the clinician distinguish an access problem from a treatment plan that needs to change.
The current label allows starting after a single supervised transmucosal dose when the patient tolerates it. It does not require every patient to spend seven days on daily medication first. The clinician assesses withdrawal before initiation, observes response to the first medicine and monitors symptoms after the injection before deciding that it is safe to leave.
Ask whether the evaluation and injection are separate appointments, which site will administer the medicine and who confirms delivery. Clinical approval, insurance authorization and medication arrival are separate steps. Keep a clinician-directed medication plan in place while those steps are completed.
Follow-up covers cravings, opioid use, constipation or other side effects, injection-site healing and recovery goals. Discuss counseling and practical support that would help you. Agree on a contact route for symptoms between visits and a plan for missed appointments, travel and changes in insurance.
Bring medication containers or a current list, allergies, past treatment records and recent laboratory results if available. Tell the clinician about alcohol, benzodiazepines, sleep medicines and other sedatives. Discuss planned surgery or dental treatment before the injection. Ask how long the first visit may take and whether you need help getting home if you feel sleepy. Do not change your daily medication or timing from an online conversion chart.
Sublocade carries a boxed warning because injection into a vein can cause serious harm or death. Only a healthcare provider administers it through the restricted REMS pathway. Alcohol and other sedatives can increase breathing and overdose risks. Do not drive or operate machinery until you know how treatment affects you. Do not rub, cut or try to remove the injection depot. Seek prompt assessment for worsening pain, swelling, drainage or skin breakdown. Call 911 for slow breathing, inability to wake, a seizure or another medical emergency; use available overdose-reversal medicine for a suspected opioid overdose.
Maintenance injections are generally monthly, but the first two visits can follow a different schedule. Tell the team early if cravings or withdrawal return. A missed injection needs a clinician plan, not a borrowed film or an extra opioid. If treatment stops, buprenorphine can remain in the body for a long time, so withdrawal and medication interactions may need monitoring for months. Discuss any wish to taper without assuming that an injection guarantees a painless end to treatment.
Ask for separate estimates for evaluation, medication, administration, testing and follow-up. Confirm the authorization period and the plan if approval or shipment is delayed. Manufacturer support has its own eligibility rules and does not establish your total clinic cost. Confirm the actual administration site before arranging time away from work; confirm that the medicine and injection visit are arranged.
Ask the treatment service which locations currently administer your prescribed injection before choosing a site. An address list, manufacturer locator or regional listing does not establish that each site is actively providing this treatment. Ask the responsible service to identify the exact active site, clinician, accepted order, product delivery and appointment. Confirm those arrangements before travel or changing an existing treatment schedule.
Choose a treatment location that works for the prescribed injection schedule and follow-up. Sublocade must be administered by a healthcare professional through its REMS program. Arrange the receiving setting, medication delivery and appointment with the addiction-care team before changing your current buprenorphine plan.
Have your insurance card ready when booking. Share member details through the clinic’s confirmed secure intake process. Check with the clinic and your insurer that the exact plan covers the clinician and requested service. Ask about visit charges, any separately billed tests or medicines, and any referral or authorization requirement. Coverage and your copay or deductible depend on the plan; request a written estimate if paying yourself.
Stopping needs an individualized plan. Long-acting buprenorphine can delay withdrawal, and some patients need months of follow-up after the last injection. Forum reports of an easy taper cannot predict your experience. Review cravings, relapse risk and ongoing support before deciding to stop.
No. Coverage approval, medication acquisition and a confirmed administration visit are separate tasks. Ask which step is complete and what remains, and request the total expected costs rather than relying on a medicine-only estimate.
The Sublocade family currently covers Brooklyn, Queens, the Bronx, Manhattan, and Long Island so the treatment plan does not depend on one hard-to-reach clinic.
Each location carries the same core treatment framing, then adds local directions, the address, and a booking path that fits repeat monthly follow-up.
Choosing the right site is not just about the first visit. It is also about whether the patient can realistically return every month for ongoing care.
The broader MAT network still matters. Some patients also need same-day evaluation, bridge planning, therapy, psychiatry, or primary care connected to the medication plan.
Bronx
932 E 174th St, Bronx, NY 10460
A Bronx option for monthly Sublocade follow-up, transition review, and practical medication coordination close to home.
View local Sublocade care Get directions
Queens
37-15 23rd Ave, Astoria, NY 11105
A western Queens location for monthly buprenorphine injection visits, benefits review, and structured addiction medicine follow-up.
View local Sublocade care Get directions
Bronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx site for Sublocade scheduling, pharmacy coordination, and repeat injection care.
View local Sublocade care Get directions
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
A central Brooklyn location for monthly injection care with realistic neighborhood access for follow-up.
View local Sublocade care Get directions
Long Island
232 W Old Country Rd, Hicksville, NY 11801
A Long Island option for Sublocade treatment, specialty-pharmacy coordination, and ongoing recovery visits.
View local Sublocade care Get directions
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
A Queens clinic for transition review, monthly injection planning, and repeat follow-up.
View local Sublocade care Get directions
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
A southeast Queens location for monthly Sublocade visits, benefits review, and addiction medicine support.
View local Sublocade care Get directions
Queens
30-07 36th Ave, Astoria, NY 11106
A workday-friendly Queens site for monthly buprenorphine injection follow-up and practical care coordination.
View local Sublocade care Get directions
Long Island
135 Mineola Blvd, Mineola, NY 11501
A core Long Island location for monthly injection treatment, scheduling, and pharmacy coordination.
View local Sublocade care Get directions
Manhattan
259 1st Ave, New York, NY 10003
A Manhattan option for structured monthly Sublocade follow-up and reliable in-city access.
View local Sublocade care Get directions
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
A Brooklyn location for monthly injection care, transition planning, and repeat follow-up visits.
View local Sublocade care Get directionsThe first question is not just whether someone wants the injection. It is whether recent opioid use, current buprenorphine treatment, and medication tolerance support a safe transition.
The first phase covers evaluation, transition review when needed, benefits confirmation, and medication coordination so the plan is lined up before a treatment slot is used.
Sublocade is not picked up from a standard retail pharmacy. The medication is coordinated through certified handling pathways and administered by a provider in clinic.
Broader MAT visits across the network cover same-day access, bridge planning, fentanyl dependence, and local treatment options.
Daily buprenorphine treatment remains an important option for many patients before or alongside any discussion of longer-acting injectable care.
A separate injectable pathway is available when the question is monthly naltrexone rather than monthly buprenorphine.
Medication comparison separates Suboxone, Sublocade, Vivitrol, and naloxone safety planning so patients can understand which question each one answers.
Buprenorphine guidance explains how daily treatment and longer-acting injection care fit into the broader medication plan.
Telemedicine can support evaluation and follow-up when clinically appropriate, with local locations available when in-person care is needed.
When the immediate issue is how fast someone can be evaluated and started safely, the same-day pathway matters more than the injection discussion.
Short-gap medication questions are handled through the bridge pathway rather than improvised refill assumptions.
Recent fentanyl exposure can change how buprenorphine-based treatment is approached and timed.
Arrange an evaluation to discuss suitable care, preparation and follow-up with a clinician.
See active Sublocade locationsNao Medical provides outpatient addiction care. The first visit can focus on the immediate clinical question and medication planning when relevant. When wanted or clinically recommended, the care plan can also include counseling, recovery support, and closer follow-up. Related information: outpatient addiction care.
Patients who want more support can add counseling, relapse-prevention work, care coordination, and recovery follow-up through the outpatient addiction program.
Coverage depends on your exact plan, clinician, location and service. Check participation and expected charges with the clinic and your insurer before booking. Review addiction-treatment insurance support
Content was updated August 2, 2026 from the cited sources and Nao Medical's current service information. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.